U.S. Real Estate Stock News

NYSE:CVSA
NYSE:CVSAConsumer Services

Is Covista (CVSA) Offering Value After Recent Share Price Gains?

This article walks through key numbers to help you judge whether Covista is priced attractively or already fully valued, so you can compare the stock against your own expectations. Covista recently closed at US$118.07, with returns of 4.3% over the last week, 0.1% over the past month, 13.0% year to date and 4.7% over the last year. Recent coverage around Covista has focused on its share price performance and how investors are reassessing the stock in light of broader sector moves. This...
NYSE:LEN
NYSE:LENConsumer Durables

Is It Time To Reassess Lennar (LEN) After Its Recent Share Price Slide

If you are wondering whether Lennar’s current share price reflects its real worth, you are not alone. This article focuses on what the numbers say about value rather than short term market noise. The stock recently closed at US$86.20, with returns of a 6.6% decline over 7 days, a 0.3% decline over 30 days, a 17.3% decline year to date and a 17.3% decline over 1 year, putting recent price moves firmly on investors’ radar. Recent coverage has highlighted Lennar in the context of broader...
NYSE:CCI
NYSE:CCISpecialized REITs

Is Crown Castle (CCI) Offering Value After Short Term Rebound And Multi Year Slump

If you are wondering whether Crown Castle stock is priced attractively right now, the recent mix of short term gains and longer term weakness makes the valuation story especially interesting. The share price closed at US$89.10, with returns of 3.4% over 7 days and 5.1% over 30 days. Year to date the stock is up 0.5%, but down 12.3% over 1 year, 10.2% over 3 years and 38.1% over 5 years. Recent headlines have focused on Crown Castle's position within U.S. telecom infrastructure and how...
NYSE:RCUS
NYSE:RCUSBiotechs

Is It Too Late To Consider Arcus Biosciences (RCUS) After Its 221% One Year Surge?

If you are wondering whether Arcus Biosciences is reasonably priced or getting ahead of itself, the current share price invites a closer look at what investors may actually be paying for. The stock last closed at US$26.06, with returns of 5.1% over the past 7 days, 13.5% over 30 days, 11.9% year to date, and 220.9% over the last year, which points to a stock that has already seen significant movement. Recent coverage around Arcus Biosciences has focused on its position in the biotech space...
NYSE:RBLX
NYSE:RBLXEntertainment

Roblox Taps Sunil Rao To Turn India Growth Into Monetization

Roblox (NYSE:RBLX) has appointed Sunil Rao as Managing Director for India. Rao is tasked with leading local strategy and supporting growth in one of Roblox's fastest expanding international markets. This is Roblox's first direct senior leadership hire in India, focused on expanding the creator ecosystem and user base. Roblox runs a user generated content gaming and social platform where players and creators interact through virtual worlds. As global gaming, social interaction and digital...
NYSE:NJR
NYSE:NJRGas Utilities

New Jersey Resources (NJR) Margin Compression Tests Clean Energy Growth Narrative In Q2 2026 Results

New Jersey Resources (NJR) has just reported its Q2 2026 results, with Q1 fiscal 2026 revenue at US$604.9 million and EPS of US$1.22 setting the tone for how the year is shaping up for the utility. Over the past few quarters, revenue has ranged from US$298.9 million to US$913.0 million while EPS has moved between a loss of US$0.15 and a high of US$2.04. This gives a clear sense of how earnings and the top line have tracked across different periods. With trailing net margin at 15.2% and the...
NYSE:MGM
NYSE:MGMHospitality

Is MGM Resorts (MGM) Attractive After A 20.7% Year Gain And Recent Pullback?

Wondering if MGM Resorts International at around US$37.91 is a bargain or already pricing in the story? This article walks through what the current valuation signals might mean for you. The stock is up 20.7% over the last year, with returns of 3.9% year to date and 3.4% over the last month. However, the most recent week saw a 4.6% decline. Recent headlines around MGM Resorts International have focused on the company as a key player in US leisure and entertainment, with investors weighing how...
NasdaqGS:UPST
NasdaqGS:UPSTConsumer Finance

Is It Time To Reconsider Upstart Holdings (UPST) After Recent Share Price Swings?

If you are wondering whether Upstart Holdings at around US$31.17 is priced for a comeback or still carrying too much risk, the starting point is to understand what the current market value really reflects. The stock has been volatile, with a 5.1% decline over the last 7 days, a 21.9% gain over the last 30 days, a 32.0% decline year to date, and a 39.4% decline over the last year. The 3-year return sits at 121.2%, and the 5-year return at a 65.1% decline. Recent coverage around Upstart often...
NYSE:TDAY
NYSE:TDAYMedia

The Bull Case For USA TODAY (TDAY) Could Change Following Q1 Profit Rebound On Digital And AI Deals

In the first quarter of 2026, USA TODAY Co., Inc. reported revenue of US$548.49 million, down from US$571.57 million a year earlier, while turning a prior net loss of US$7.33 million into net income of US$19.89 million. The company credited improved profitability to growing digital revenue, AI-related licensing deals, and subscription gains, and reiterated full-year 2026 guidance calling for flat to slightly lower revenue but higher net income compared with last year. Next, we will examine...
NasdaqGS:CNOB
NasdaqGS:CNOBBanks

A Look At ConnectOne Bancorp (CNOB) Valuation After Strong Q1 Earnings And Dividend Increase

Q1 earnings and dividend move draw fresh attention to ConnectOne Bancorp stock ConnectOne Bancorp (CNOB) just reported first quarter results with higher net interest income, net income and earnings per share versus a year ago, alongside an 8.3% increase in its quarterly common dividend. See our latest analysis for ConnectOne Bancorp. At a share price of $30.08, ConnectOne Bancorp has a 30 day share price return of 11.28% and a year to date share price return of 15.16%, alongside a 1 year...
NasdaqGM:NTLA
NasdaqGM:NTLABiotechs

ARK Invest’s NTLA Buy Puts Dilution And CRISPR Progress In Focus

ARK Invest recently acquired over 3 million Intellia Therapeutics shares, worth more than US$43 million. The purchase reflects increased institutional interest in Intellia Therapeutics, which trades under ticker NasdaqGM:NTLA. This transaction follows earlier coverage that focused on Intellia's clinical programs, regulatory updates, and financial position. Intellia Therapeutics focuses on CRISPR/Cas9-based therapeutics, an area that many investors watch closely as gene editing moves from...
NYSE:MKL
NYSE:MKLInsurance

A Look At Markel Group (MKL) Valuation As Shares Trade Below Narrative Fair Value

Markel Group stock performance snapshot Markel Group (MKL) has seen mixed recent trading, with the stock up roughly 0.8% over the past day but showing declines over the past week, month, past 3 months and year to date. Over the past year, Markel Group reports revenue of US$16.0b and net income of US$1.7b, with its diversified operations spanning specialty insurance, industrial businesses, financial services and various consumer focused subsidiaries. See our latest analysis for Markel...
NasdaqCM:SLNO
NasdaqCM:SLNOBiotechs

A Look At Soleno Therapeutics (SLNO) Valuation After Recent Share Momentum And VYKAT XR Launch Progress

Soleno Therapeutics stock overview Soleno Therapeutics (SLNO) has drawn investor attention after recent share performance, with the stock showing a one-month return of 34.01% and a three-month return of 25.64%. See our latest analysis for Soleno Therapeutics. That recent momentum sits against a mixed longer record, with a 34.01% 1 month share price return and 25.64% 3 month share price return contrasting with a 28.21% 1 year total shareholder return decline but a very large 3 year total...
NYSE:CAG
NYSE:CAGFood

Is There Now An Opportunity In Conagra Brands (CAG) After Prolonged Share Price Weakness

If you are wondering whether Conagra Brands at around US$14 still reflects the underlying business, the current share price alone does not tell the full story. The stock has seen a 1.9% decline over the last week, a 10.9% decline over the last month, and is down 19.1% year to date and 34.9% over the last year, which will naturally raise questions about how the market is assessing its risks and potential. These weaker recent returns sit against a longer backdrop, with the stock down 55.6%...